Send me a link:

*Text messaging rates may apply.

 Dow Down0.04% Nasdaq Up0.42%

More On DNAG

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


DNAPrint Genomics, Inc. (DNAG)

-Other OTC
0.00 0.00(0.00%) Jul 22
ProfileGet Profile for:
DNAPrint Genomics, Inc.
1621 West University Parkway
Sarasota, FL 34243
United States - Map
Phone: 941-366-3400
Fax: 941-952-9770
Website: http://www.dnaprint.com

Details 
Index Membership:N/A
Sector:N/A
Industry:N/A
Full Time Employees:24

Business Summary 

DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients. DNAPrint Genomics, Inc. was formerly known as Lexington Energy, Inc. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on DNAPrint Genomics, Inc.

Key Executives 
 PayExercised
Dr. Tony N. Frudakis Ph.D., 45
Founder, Chief Scientific Officer, Sec. and Director
N/AN/A
Dr. Barbara Handelin Ph.D.,
Director of Diagnostics, Gen. Mang. of Computational Biology and Head of New Internal Program In Diagnostics
N/AN/A
Mr. Matthew Thomas ,
Exec. Officer
N/AN/A
Mr. Jatin Patel ,
Exec. Officer
N/AN/A
Dr. Laurence A. Rubin M.D., FRCPC FACP,
Exec. Officer
N/AN/A
Amounts are as of Dec 31, 2006 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.